Sanofi receives Investment Bank Analyst Rating Update
- ByInvesting.com-
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sanofi SA (SASY)
95.48
-1.37(-1.41%)
- Volume:1,911,553
- Bid/Ask:0.00/0.00
- Day's Range:94.71 - 95.77
SASY News
- Prev. Close
- 96.85
- Day's Range
- 94.71-95.77
- Revenue
- 42.04B
- Open
- 95.23
- 52 wk Range
- 80.95-106.66
- EPS
- 5.3
- Volume
- 1,911,553
- Market Cap
- 119.54B
- Dividend (Yield)
- 3.33(3.49%)
- Average Volume (3m)
- 1,932,879
- P/E Ratio
- 18.43
- Beta
- 0.363
- 1-Year Change
- 9.68%
- Shares Outstanding
- 1,252,001,967
- Next Earnings Date
- 27 Oct 2022
What is your sentiment on Sanofi?
or
Market is currently closed. Voting is open during market hours.
Sanofi SA News
- Quest to Cut Prescription Drug Prices Puts Insulin in Spotlight
- ByInvesting.com-
By Liz MoyerInvesting.com -- Lawmakers are once again trying to get caps on prescription drug pricing across the finish line, and that puts insulin in the spotlight.The market...
- Sanofi PT receives Investment Bank Analyst Rating Update
- ByInvesting.com-
Sanofi SA Analysis
- Week In Review: Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In China
- ByTalkmarkets-
Suzhou Innovent Biologics will develop two Sanofi cancer candidates for China use in a complicated deal with money due to each company. Sanofi will initially invest $305 million in...
- Daily Stock Analysis: Sanofi S.A.
- ByTalkmarkets-
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. It was founded in 1973 and is headquartered in...
- C4X Discovery receives Sanofi milestone payment
- ByTipRanks-
C4X Discovery Holdings plc C4X Discovery receives first milestone payment from Sanofi €3 million milestone payment triggered by pre-clinical progression in oral IL-17A inhibitor...
Sanofi SA Company Profile
Sanofi SA Company Profile
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.
Read More
Technical Summary
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Neutral | Sell | Strong Sell | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Buy | Buy | Strong Sell | Strong Sell | Strong Buy |
Trending Stocks
Trending Stocks
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 123.20 | 123.80 | 121.30 | +2.40 | +1.99% | 3.26M | London | |||
| 91.15 | 93.15 | 90.20 | -0.65 | -0.71% | 698.51K | London | |||
| 214.20 | 217.40 | 213.40 | -2.50 | -1.15% | 5.15M | London | |||
| 165.86 | 167.62 | 164.64 | -0.14 | -0.08% | 46.92M | London | |||
| 553.50 | 556.40 | 544.40 | +8.00 | +1.47% | 13.94M | London | |||
| 1.315 | 1.28 | 1.22 | -0.070 | -5.18% | 10.27M | London | |||
| 660.40 | 669.60 | 660.40 | -6.00 | -0.90% | 891.72K | London | |||
| 92.00 | 92.90 | 91.60 | -0.30 | -0.33% | 398.66K | London | |||
| 596.50 | 608.00 | 593.50 | -14.50 | -2.37% | 282.56K | London | |||
| 84.66 | 87.06 | 84.17 | -2.04 | -2.35% | 31.00M | London | |||
| 144.50 | 145.00 | 144.50 | +3.50 | +2.48% | 371.69K | London | |||
| 115.10 | 115.10 | 112.70 | +2.00 | +1.77% | 452.41K | London | |||
| 193.60 | 197.10 | 192.00 | -2.40 | -1.22% | 595.26K | London | |||
| 410.50 | 411.50 | 409.00 | -1.00 | -0.24% | 622.35K | London | |||
| 0.51 | 0.51 | 0.51 | -0.005 | -0.97% | 2.83M | London |
- 2 hours agoThe best way to create great profit on trading is to get a precise signals to execute. I continue to get my signals from Douglas Troves . I have made over 13k from crypto in 3 days using his signals notwithstanding the market slump You can get in touch with him through Face 📙 book: 👉Douglas Troves 👈 for daily signals Whats 👤 App ➡️ +1 641 276 9476 for guide to professional trade
- 11 Dec 2020, 09:36there is no future for it